The CHN2 gene encodes the β2-chimaerin, a Rac specific GTPase activating protein with an important role in the establishment of functional brain circuitry by controlling axon pruning. Genetic studies suggest that the CHN2 gene harbors variants that contribute to addiction vulnerability and smoking behavior. To further evaluate the role of β2-chimaerin in nicotine addiction, we investigated the association of three individual polymorphisms of the CHN2 gene with smoking dependence.
INTRODUCTION
Tobacco addiction is a complex brain disorder that involves multiple molecular components and has a strong genetic influence [1] . Numerous factors contribute to the long lasting nature of tobacco addiction, such as the structural changes induced by nicotine in neurons and its effect on synaptic plasticity [2] . Actin cytoskeleton drives the neuroadaptations produced by nicotine, and therefore, several genes encoding proteins involved in cytoskeleton regulation harbor allelic variants that contribute to smoking dependence [3] . Among these, the CHN2 gene has been identified in genomewide association studies (GWAS) of nicotine dependence as a candidate for harboring variants involved in smoking addiction [4] . The human CHN2 gene maps to chromosome 7p15.3, has 13 exons and encodes the β2-chimaerin, a GTPase activating protein (GAP) highly expressed in the brain [5] . β2-chimaerin selectively inactivates Rac, a small GTPase with a prominent role in the control of actin cytoskeleton dynamics [6, 7] . Recent work in animal models has demonstrated the essential role of β2-chimaerin in controlling axon pruning in the hippocampus [8] . In humans, the missense polymorphism (H204R) on the CHN2 gene is associated with schizophrenia [9], a disorder with high rate of comorbidity with smoking [10] . Considering the evidences for the involvement of the CHN2 gene in tobacco addiction, we focused this study on identifying the association of individual SNPs on the CHN2 gene with smoking. We analyzed three polymorphisms of potential relevance for β2-chimaerin function: polymorphism rs3750103 c.611A>G (p.H204R) in exon 7 previously associated with schizophrenia, polymorphism rs12112301 (IVS5+7C>T) located on intron 5 that could influence on splicing, and polymorphism rs186911567 c.366G>A (p.S122S) in exon 6, a novel synonymous polymorphism recently identified in our laboratory.
MATERIALS AND METHODS

Subjects
The three SNPs were genotyped in 361 Caucasians from Castilla y León, Spain. 173 participants were current smokers (mean age 60.4 ±1.4 years, 74.0 % males) which fulfilled the DMS-IV criteria for nicotine dependence dictated by the American Psychiatric Association, and were referred to the Tobacco Addiction Unit of the University Hospital of Salamanca, Spain. The control group consisted of 188 subjects (mean age 45.9 ± 1.4 years, 75.0% males) which had a lifetime history of no more than 100 cigarettes without developing an addiction to tobacco. Neither smokers nor controls had any mental disorder, or personal or familiar history of lung cancer. All subjects gave informed consent to participate, and the study was approved by institutional ethical committees.
Genotyping
Genotypes of the rs12112301 and rs3750103 polymorphisms were determined using the TaqMan 5´-exonuclease allelic distribution assay (Applied Biosystems, Foster City, USA). The rs186911567 polymorphism was studied by PCR-restriction fragment length polymorphism-based analysis and digestion with TaqI. Primers used for the amplification were forward: 5'-TATCATTCCACACTGTGCTTAT-3', and reverse: 5'-TCAGCAAATCGCACCTATAGT-3'. The amplified 433 bp fragment was digested overnight at 65 °C with TaqI and the resulting fragments (298 bp and 135 bp for A allele and 433 bp for G allele) were separated on a 3% agarose gel.
Statistical analysis
Hardy-Weinberg equilibrium was determined with the χ 2 test. Genotype frequencies of smokers and controls, and smokers´ subgroups, were compared by means of χ 2 test and Fisher's exact test when necessary (expected values below 5). P < 0.05 was considered as significant for the differences between the genotypes. All statistical analyses were performed using the statistical software SPSS v.19.0 (SPSS Inc., Chicago, IL). Table 1 shows genotype distributions of the three polymorphisms of the CHN2 gene among the smokers and controls. Frequencies of the rs12112301 and rs3750103
RESULTS
polymorphisms were in Hardy-Weinberg equilibrium in the control group and no significant differences were observed among smokers and controls. However, we found a significant difference in the frequency of the rs186911567 polymorphism between smokers and controls. 4.6% of smokers had the GA or AA genotypes while no carriers of the A allele were found in the control group (p = 0.003). Hardy-Weinberg equilibrium was not considered for this polymorphism in the control group since only carriers of the GG genotype were found in these subjects.
To determine the factors contributing to the association of the rs186911567 polymorphism with smoking, we next analyzed this polymorphism in smokers grouped according to their age and smoking habits ( Table 2 ). There was no significant association of this polymorphism with the daily cigarette consumption (up to or more than 20), years of smoking (up to or more than 30) or age (>65 vs. <65). However, there was a trend towards an increased frequency of the polymorphism in older smokers (p = 0.07). 7.5% of smokers older than 65 had the GA or AA genotypes, while only 1.25% of smokers younger than 65 had the GA genotype and no carriers of the AA genotype were found in this group. These data suggest that the rs186911567 polymorphism does not influence smoking quantity (estimated by the number of cigarettes smoked per day) but may influence duration of smoking. Other pathways may also contribute to the role of 2-chimaerin on nicotine
DISCUSSION
dependence. Recent data demonstrate that the effects of nicotine on learning and memory are in part mediated by JNK signaling in the hippocampus, which may explain 9 the long-lasting modifications of behavior induced by nicotine that contributes to addiction [16] . It is plausible that 2-chimaerin regulates JNK activity in hippocampal neurons since it has been reported the expression of this protein in the hippocampus [8] and the role of 2-chimaerin in the regulation of JNK has been already demonstrated in epithelial cells [17] .
In summary, our study is the first report of a novel SNP polymorphism of the Table 2 Genotype frequencies of the CHN2 rs186911567 c.366G>A (p.S122S) polymorphism in smokers with different age and smoking behavior
